| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-06 |